Clinical Trial Update: Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma Concentration [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating an optimal simvastatin formulation for uniform time to maximum plasma concentration in Celiac disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Zurich | Conditions: Celiac Disease | Phase 1 | Status: TERMINATED